These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1337372)

  • 1. Rationale for the use of the ACTH4-9 analogue ORG 2766 in the treatment of diabetic neuropathy.
    Bravenboer B; Erkelens DW; Gispen WH
    Neth J Med; 1992 Dec; 41(5-6):255-8. PubMed ID: 1337372
    [No Abstract]   [Full Text] [Related]  

  • 2. Protection of cisplatin-induced neuropathy: recent developments.
    Hamers F; Neijt J; Gispen W
    Pathol Biol (Paris); 1992 Nov; 39(9):829-30. PubMed ID: 1311436
    [No Abstract]   [Full Text] [Related]  

  • 3. Randomized double-blind placebo-controlled trial to evaluate the effect of the ACTH4-9 analogue ORG 2766 in IDDM patients with neuropathy.
    Bravenboer B; Hendrikse PH; Oey PL; van Huffelen AC; Groenhout C; Gispen WH; Erkelens DW
    Diabetologia; 1994 Apr; 37(4):408-13. PubMed ID: 8063043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, multicenter, double-blind, placebo-controlled, dose-finding study of ORG 2766 in the prevention or delay of cisplatin-induced neuropathies in women with ovarian cancer.
    Roberts JA; Jenison EL; Kim K; Clarke-Pearson D; Langleben A
    Gynecol Oncol; 1997 Nov; 67(2):172-7. PubMed ID: 9367703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of the neuropeptide ORG.2766 in the prevention and treatment of cisplatin-induced neurotoxicity in rats.
    Gerritsen van der Hoop R; de Koning P; Boven E; Neijt JP; Jennekens FG; Gispen WH
    Eur J Cancer Clin Oncol; 1988 Apr; 24(4):637-42. PubMed ID: 2838292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of an ACTH(4-9) analogue on cisplatin neuropathy of longstanding duration: a phase II study.
    Hilkens PH; van der Burg ME; Moll JW; van den Bent MJ; van Putten WL; Vecht CJ
    Clin Neurol Neurosurg; 1995 May; 97(2):139-41. PubMed ID: 7656487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of an ACTH (4-9) analogue on development of cisplatin neuropathy in testicular cancer: a randomized trial.
    van Gerven JM; Hovestadt A; Moll JW; Rodenburg CJ; Splinter TA; van Oosterom AT; Keizer L; Drogendijk TE; Groenhout CM; Vecht CJ
    J Neurol; 1994 Jun; 241(7):432-5. PubMed ID: 7931444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An ACTH-(4-9) analogue, Org 2766, improves recovery from acrylamide neuropathy in rats.
    Sporel-Ozakat RE; Edwards PM; Van der Hoop RG; Gispen WH
    Eur J Pharmacol; 1990 Sep; 186(2-3):181-7. PubMed ID: 1963145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trial of an ACTH4-9 Analogue (ORG 2766) in children with intractable seizures.
    Pentella K; Bachman DS; Sandman CA
    Neuropediatrics; 1982 May; 13(2):59-62. PubMed ID: 6290927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurotrophic effects of ACTH/MSH neuropeptides.
    de Wied D
    Acta Neurobiol Exp (Wars); 1990; 50(4-5):353-66. PubMed ID: 1966658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cisplatin-induced neuropathy in mature rats: effects of the melanocortin-derived peptide ORG 2766.
    Hamers FP; Pette C; Bravenboer B; Vecht CJ; Neijt JP; Gispen WH
    Cancer Chemother Pharmacol; 1993; 32(2):162-6. PubMed ID: 8387400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of synthetic neuropeptides in psycho-organic brain syndrome. Results with ACTH4-10 and ACTH4-9-analog (author's transl)].
    Schneider E; Jacobi P; van Riezen H; Voerman JW; Fischer PA
    Pharmacopsychiatria; 1981 Sep; 14(5):155-9. PubMed ID: 6270708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anticonvulsive properties of peptide ACTH4-7 pro-gly-pro detected in amygdaloid kindling and audiogenic epilepsy in rats].
    Chepurnov SA; Chepurnova NE; Artiukhova MV; Kuznetsova EIu; Nezavibat'ko VN
    Biull Eksp Biol Med; 1989 Jun; 107(6):702-4. PubMed ID: 2551416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of diabetic polyneuropathy with the neurotrophic peptide ORG 2766.
    Valk GD; Kappelle AC; Tjon-A-Tsien AM; Bravenboer B; Bakker K; Michels RP; Groenhout CM; Bertelsmann FW
    J Neurol; 1996 Mar; 243(3):257-63. PubMed ID: 8936356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ACTH (4-9) analog ORG 2766 in panic disorder: a preliminary study.
    den Boer JA; Westenberg HG; Mastenbroek B; van Ree JM
    Psychopharmacol Bull; 1989; 25(2):204-8. PubMed ID: 2557650
    [No Abstract]   [Full Text] [Related]  

  • 16. Cisplatin chemoprotection and rescue: pharmacologic modulation of toxicity.
    Gandara DR; Perez EA; Weibe V; De Gregorio MW
    Semin Oncol; 1991 Feb; 18(1 Suppl 3):49-55. PubMed ID: 1848372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphological and electrophysiological study of the effects of cisplatin and ORG.2766 on rat spinal ganglion neurons.
    Müller LJ; Gerritsen van der Hoop R; Moorer-van Delft CM; Gispen WH; Roubos EW
    Cancer Res; 1990 Apr; 50(8):2437-42. PubMed ID: 2156619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The course of neuropathy after cessation of cisplatin treatment, combined with Org 2766 or placebo.
    Hovestadt A; van der Burg ME; Verbiest HB; van Putten WL; Vecht CJ
    J Neurol; 1992 Mar; 239(3):143-6. PubMed ID: 1315383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection by an ACTH4-9 analogue against the toxic effects of cisplatin and taxol on sensory neurons and glial cells in vitro.
    Hol EM; Mandys V; Sodaar P; Gispen WH; Bär PR
    J Neurosci Res; 1994 Oct; 39(2):178-85. PubMed ID: 7837287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ACTH/MSH like peptides in the treatment of cisplatin neuropathy.
    Gispen WH; Hamers FP; Vecht CJ; Jennekens FG; Neyt JP
    J Steroid Biochem Mol Biol; 1992 Sep; 43(1-3):179-83. PubMed ID: 1326318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.